Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers

por Mushtaq, Muhammad Umair, Papadas, Athanasios, Pagenkopf, Adam, Flietner, Evan, Morrow, Zachary, Chaudhary, Sibgha Gull, Asimakopoulos, Fotis
Publicado 2018

Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model

por Flietner, Evan, Wen, Zhi, Rajagopalan, Adhithi, Jung, Oisun, Watkins, Lyndsay, Wiesner, Joshua, You, Xiaona, Zhou, Yun, Sun, Yuqian, Kingstad-Bakke, Brock, Callander, Natalie S., Rapraeger, Alan, Suresh, M., Asimakopoulos, Fotis, Zhang, Jing
Publicado 2022

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment

por Papadas, Athanasios, Deb, Gauri, Cicala, Alexander, Officer, Adam, Hope, Chelsea, Pagenkopf, Adam, Flietner, Evan, Morrow, Zachary T., Emmerich, Philip, Wiesner, Joshua, Arauz, Garrett, Bansal, Varun, Esbona, Karla, Capitini, Christian M., Matkowskyj, Kristina A., Deming, Dustin A., Politi, Katerina, Abrams, Scott I., Harismendy, Olivier, Asimakopoulos, Fotis
Publicado 2022